modakafusp alfa
takeda
['modakafusp']
.565 final results from the first-in-human phase 1/2 study of modakafusp alfa, an immune-targeting attenuated cytokine, in patients w/ rrmm #ash22 #imfash22 #myeloma 
VP Support Groups @IMFmyeloma. Husband, @IMFmikeMYELOMA dx w/ #myeloma 2000. The views & opinions expressed are my own & do not express views of my employer.